JP6533466B2 - 抗菌性化合物、その合成およびその適用 - Google Patents
抗菌性化合物、その合成およびその適用 Download PDFInfo
- Publication number
- JP6533466B2 JP6533466B2 JP2015548841A JP2015548841A JP6533466B2 JP 6533466 B2 JP6533466 B2 JP 6533466B2 JP 2015548841 A JP2015548841 A JP 2015548841A JP 2015548841 A JP2015548841 A JP 2015548841A JP 6533466 B2 JP6533466 B2 JP 6533466B2
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- group
- boc
- compound
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN5299CH2012 | 2012-12-18 | ||
| IN5299/CHE/2012 | 2012-12-18 | ||
| PCT/IB2013/061090 WO2014097178A1 (en) | 2012-12-18 | 2013-12-18 | Antimicrobial compounds, their synthesis and applications thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016504330A JP2016504330A (ja) | 2016-02-12 |
| JP2016504330A5 JP2016504330A5 (cg-RX-API-DMAC7.html) | 2017-01-26 |
| JP6533466B2 true JP6533466B2 (ja) | 2019-06-19 |
Family
ID=54148251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548841A Expired - Fee Related JP6533466B2 (ja) | 2012-12-18 | 2013-12-18 | 抗菌性化合物、その合成およびその適用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9783490B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2934563B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6533466B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104981249B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013365769B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015014391B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2894202A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1210437A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014097178A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105566149B (zh) * | 2016-03-02 | 2017-05-24 | 郑州大学 | 具有抗菌活性的查尔酮阳离子抗菌肽模拟物及其制备方法 |
| CN106995384B (zh) * | 2017-04-21 | 2018-12-11 | 郑州大学 | 具有抗菌活性的二烷基阳离子两亲性抗菌肽模拟物及其制备方法 |
| CN120118207A (zh) | 2017-12-15 | 2025-06-10 | 丹娜-法伯癌症研究院有限公司 | 稳定肽-介导的靶向蛋白降解 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07501085A (ja) | 1992-09-03 | 1995-02-02 | ベーリンガー インゲルハイム コマンディトゲゼルシャフト | 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物 |
| US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
| JPH09507846A (ja) * | 1993-12-30 | 1997-08-12 | スミスクライン・ビーチャム・コーポレイション | フェニルメチルヘキサンアミドおよびその使用 |
| US5663148A (en) | 1994-07-12 | 1997-09-02 | Abbott Laboratories | Anaphylatoxin receptor ligands containing lipophilic residues |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| AU697565B2 (en) | 1995-12-12 | 1998-10-08 | Taiho Pharmaceutical Co., Ltd. | Epoxysuccinamide derivative or salt thereof and medicine comprising the same |
| CA2217550A1 (en) * | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
| RU2200154C2 (ru) * | 1997-12-12 | 2003-03-10 | Дайичи Файн Кемикал Ко., Лтд. | Новые ингибиторы металлопротеиназ |
| AU2180201A (en) * | 1999-11-30 | 2001-06-12 | Aventis Pharma S.A. | Hydroxamic acid macrocyclic derivatives, preparation method and compositions containing same |
| JP2002161084A (ja) * | 2000-11-28 | 2002-06-04 | Sumitomo Pharmaceut Co Ltd | 複素環誘導体 |
| US7393836B2 (en) | 2004-07-06 | 2008-07-01 | Boehringer Ingelheim International Gmbh | D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| GB0512751D0 (en) * | 2005-06-22 | 2005-07-27 | Glaxo Group Ltd | New adjuvant |
| US20080118525A1 (en) * | 2006-10-04 | 2008-05-22 | Oreola Donini | Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| US8097582B2 (en) * | 2006-05-09 | 2012-01-17 | Neobiotics Ab | Peptide derivatives useful as antimicrobial agents and for treating wounds |
| JP2010512417A (ja) * | 2006-12-11 | 2010-04-22 | ワイス エルエルシー | イオンチャネルモジュレータ− |
| CN102757477B (zh) * | 2011-04-27 | 2014-09-03 | 首都医科大学 | 烯丙基半胱氨酰氨基酸甲酯衍生物及其合成方法和应用 |
| DK2709619T3 (en) * | 2011-05-16 | 2018-01-15 | Cellceutix Corp | RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS |
-
2013
- 2013-12-18 CA CA2894202A patent/CA2894202A1/en not_active Abandoned
- 2013-12-18 HK HK15111327.4A patent/HK1210437A1/xx unknown
- 2013-12-18 US US14/652,714 patent/US9783490B2/en not_active Expired - Fee Related
- 2013-12-18 CN CN201380070984.4A patent/CN104981249B/zh not_active Expired - Fee Related
- 2013-12-18 EP EP13865950.3A patent/EP2934563B1/en active Active
- 2013-12-18 AU AU2013365769A patent/AU2013365769B2/en not_active Ceased
- 2013-12-18 JP JP2015548841A patent/JP6533466B2/ja not_active Expired - Fee Related
- 2013-12-18 WO PCT/IB2013/061090 patent/WO2014097178A1/en not_active Ceased
- 2013-12-18 BR BR112015014391-1A patent/BR112015014391B1/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2894202A1 (en) | 2014-06-26 |
| JP2016504330A (ja) | 2016-02-12 |
| WO2014097178A1 (en) | 2014-06-26 |
| BR112015014391A2 (pt) | 2017-07-11 |
| EP2934563A4 (en) | 2016-08-17 |
| US20150329478A1 (en) | 2015-11-19 |
| HK1210437A1 (en) | 2016-04-22 |
| US9783490B2 (en) | 2017-10-10 |
| CN104981249B (zh) | 2018-06-19 |
| EP2934563A1 (en) | 2015-10-28 |
| BR112015014391B1 (pt) | 2020-11-03 |
| EP2934563B1 (en) | 2020-07-08 |
| AU2013365769B2 (en) | 2018-03-15 |
| CN104981249A (zh) | 2015-10-14 |
| AU2013365769A1 (en) | 2015-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3594223B1 (en) | Treatment of biofilms | |
| US11325955B2 (en) | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections | |
| Wang et al. | Design and synthesis of 3-hydroxy-pyridin-4 (1 H)-ones–ciprofloxacin conjugates as dual antibacterial and antibiofilm agents against Pseudomonas aeruginosa | |
| JP2004501166A (ja) | 化学修飾ペプチド、組成物、並びに製造方法および使用 | |
| Qian et al. | H2S-releasing amphiphilic dipeptide hydrogels are potent S. aureus biofilm disruptors | |
| JP2020050676A (ja) | 抗菌性治療薬及び予防薬 | |
| Gou et al. | Bio-inspired peptide decorated dendrimers for a robust antibacterial coating on hydroxyapatite | |
| Li et al. | Synthesis and bioactivities of new N-terminal dipeptide mimetics with aromatic amide moiety: Broad-spectrum antibacterial activity and high antineoplastic activity | |
| EP2934563B1 (en) | Antimicrobial compounds, their synthesis and applications thereof | |
| JP2021178855A (ja) | ヒストンデアセチラーゼの阻害剤としての大環状分子のチオエステルプロドラッグ | |
| WO2019079759A1 (en) | ANTI-PERSISTENCE AND ANTI-VIRULENCE COMPOUNDS WITH BROAD SPECTRUM | |
| AU2012338461B2 (en) | Cationic antibacterial composition | |
| CN107106533B (zh) | 用于治疗微生物感染的增效组合物 | |
| US9738684B2 (en) | N-terminally modified linear and branched polyamine conjugated peptidomimetics as antimicrobials agents | |
| JP2018530738A (ja) | 緑膿菌阻害化合物 | |
| CN118388589A (zh) | 一种抗胞内细菌的细胞穿透型抗菌肽及其制备方法和应用 | |
| Singh et al. | Design, synthesis and biological profiling of novel phenothiazine derivatives as potent antitubercular agents | |
| JPH10316666A (ja) | 新規ベンズオキサジンジオン誘導体、その製造方法及びその使用方法 | |
| CN108078982A (zh) | 脯氨酸衍生物在制备β-内酰胺酶抑制剂中的用途 | |
| Erol et al. | Synthesis, antimicrobial and in silico studies of new 2.5-disubstituted benzoxazole derivative | |
| War et al. | Design, synthesis and molecular docking studies of some morpholine linked thiazolidinone hybrid molecules | |
| Hachim et al. | Design, molecular docking, synthesis, and antimicrobial evaluation of new dipeptide derivatives of ceftizoxime sodium | |
| WO2025240758A1 (en) | Staphylococcus hominis daptide antibiotics, derivatives thereof, and methods of treatment | |
| CN118598783A (zh) | 巯基苯酚衍生物及其应用 | |
| EP3639816A1 (en) | Compounds for use in the treatment of bacterial infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151105 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161205 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161205 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171012 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171025 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180406 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180627 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180926 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181105 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20181207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190116 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190405 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190515 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190524 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6533466 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |